Discontinuation of L-asparaginase and poor response to prednisolone is associated with poor outcomes in ETV6::RUNX1-positive pediatric B-ALL patients, indicating drug insensitivity [53]. The gene discussed is RUNX1; the disease is acute lymphoblastic leukemia.